Post Marketing Information DHCPL 08/08/2016 Adempas® (Riociguat): New contraindication for patients with pulmonary hypertension associated with idiopathic interstitial pneumonia (PH-IIP)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Film Coated 2.5 mg National Heart Centre National University Hospital Tablet, Film Coated 1 mg National Heart Centre
ORAL Select a brand starting with the letter: A ADEMPAS FILM-COATED TABLET 0.5MG [SIN14678P] ADEMPAS FILM-COATED TABLET 1.0MG [SIN14679P] ADEMPAS FILM-COATED TABLET 1.5MG [SIN14680P] See all ADEMPAS FILM-COATED TABLET 2.0MG [SIN14681P] ADEMPAS FILM-COATED TABLET 2.5MG [SIN14682P]